| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$40 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2025 9:23AM |
$0.655 |
$0.310 |
fallen by
52.67%
|
|
AGN - Price-sensitive ASX Announcement
Full Release
Key Points
- Progress in Phase 2 clinical trial of ARG-007 with 74 patients dosed.
- ARG-006 received Orphan Drug and Rare Pediatric Designations from the FDA.
- Positive early results for ARG-007 in Alzheimer's and Parkinson's disease studies.
- Cash reserves of $15.06 million as of December 31, 2024.
- Company was cash flow positive for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pureprofile Ltd (PPL) ORDINARY FULLY PAID |
Information Technology |
$57 |
Becoming a substantial holder
|
30 Jan 2025 9:23AM |
$0.044 |
$0.049 |
risen by
11.36%
|
|
| Kingsgate Consolidated Limited (KCN) ORDINARY FULLY PAID |
Materials |
$1,609 |
December 2024 Quarterly Report
|
30 Jan 2025 9:23AM |
$1.405 |
$6.020 |
risen by
328.47%
|
|
KCN - Price-sensitive ASX Announcement
Full Release
Key Points
- 150% increase in ore mined compared to the previous quarter.
- Gold production increased by 13.4% to 17,936 ounces.
- Total silver produced was 128,037 ounces.
- Gold sales reached 17,314 ounces at an average price of US$2,664 per ounce.
- AISC for the quarter was US$2,125 per ounce.
- New reserve models are expected to deliver more accurate forecasts.
- Expectations of increased grade performance for future quarters.
- Community initiatives launched to support local education and health.
- Increased focus on efficiency and cost reduction in operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Global Lithium Resources Limited (GL1) ORDINARY FULLY PAID |
Materials |
$158 |
Global Lithium Receives $0.76m R&D Tax Incentive Rebate
|
30 Jan 2025 9:23AM |
$0.220 |
$0.605 |
risen by
175%
|
|
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$588 |
December 2024 - Quarterly Cash Flow Report
|
30 Jan 2025 9:23AM |
$0.175 |
$0.220 |
risen by
25.71%
|
|
INR - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities of $1,978,000.
- Total cash balance at end of quarter is $21,552,000.
- Staff costs and administration were major cash outflows.
- Capitalized exploration expenses contributed significantly to cash flows.
- Exploration and evaluation expenditures amounted to $2,519,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$206 |
Update - Notification of buy-back - CEH
|
30 Jan 2025 9:23AM |
$0.490 |
$0.530 |
risen by
8.16%
|
|
| Nanoveu Limited (NVU) ORDINARY FULLY PAID |
Information Technology |
$95 |
Proposed issue of securities - NVU
|
30 Jan 2025 9:22AM |
$0.029 |
$0.096 |
risen by
231.03%
|
|
| Kingsrose Mining Limited (KRM) ORDINARY FULLY PAID |
Materials |
$35 |
Kingsrose-BHP Alliances Announce High Grade Rockchips
|
30 Jan 2025 9:22AM |
$0.034 |
$0.047 |
risen by
38.24%
|
|
KRM - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsrose commenced a large-scale exploration program in Europe funded by BHP.
- US$2.7 million of the US$5.0 million budget for Year 1 has been spent on exploration activities.
- High-grade copper in polymetallic veins was discovered in Norway.
- Significant rockchip samples include 29.7% Cu, 1.1 g/t Au from Porsanger.
- Regional-scale helicopter-borne EM surveys are planned for February.
- In Central Finland, exploration activities have included extensive soil and rockchip sampling.
- Kingsrose actively engages with local communities and stakeholders during exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Saturn Metals Limited (STN) ORDINARY FULLY PAID |
Materials |
$260 |
Kappes Cassiday Appointed to Complete Feasibility Studies
|
30 Jan 2025 9:22AM |
$0.235 |
$0.475 |
risen by
102.13%
|
|
STN - Price-sensitive ASX Announcement
Full Release
Key Points
- Kappes Cassiday & Associates appointed for Apollo Hill PFS.
- Contract highlights global heap leach expertise.
- PFS based on updated Mineral Resource Estimate.
- Significant progress made since August 2023 Preliminary Economic Analysis.
- Scheduled completion of the PFS during Q4 CY2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nanoveu Limited (NVU) ORDINARY FULLY PAID |
Information Technology |
$95 |
Technology Pioneer Appointed CEO of Semiconductor Division
|
30 Jan 2025 9:22AM |
$0.029 |
$0.096 |
risen by
231.03%
|
|
NVU - Price-sensitive ASX Announcement
Full Release
Key Points
- Mark Goranson appointed as CEO of Semiconductor Technologies.
- Goranson has extensive experience in semiconductor innovations.
- Nanoveu aims to enhance AI-driven edge computing capabilities.
- Focus on ultra-low-power solutions for AI applications.
- Leadership expected to drive market expansion and operational scalability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$588 |
December 2024 - Quarterly Activities Report
|
30 Jan 2025 9:22AM |
$0.175 |
$0.220 |
risen by
25.71%
|
|
INR - Price-sensitive ASX Announcement
Full Release
Key Points
- Ioneer closes upsized US$996 million loan in January 2025 from U.S. Department of Energy.
- The Rhyolite Ridge Lithium-Boron Project completes major US Federal permitting step.
- Ioneer is now licensed to commence construction in 2025.
- The project is expected to create hundreds of jobs and generate significant tax revenue.
- Rhyolite Ridge will quadruple the nation’s current domestic lithium supply.
- The project has received separate offtake agreements with major companies like Ford and Toyota.
- Construction is targeted for later in 2025 with first production expected in 2028.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Syrah Resources Limited (SYR) ORDINARY FULLY PAID |
Materials |
$413 |
December 2024 Quarterly Activities Presentation
|
30 Jan 2025 9:21AM |
$0.230 |
$0.315 |
risen by
36.96%
|
|
SYR - Price-sensitive ASX Announcement
Full Release
Key Points
- No production at Balama due to protest actions impeding operations
- Syrah declared force majeure at Balama
- Achieved Initiative for Responsible Mining Assurance 50 level of performance for Balama
- Lower natural graphite sales due to a significantly higher proportion of lower priced fines in the sales mix
- Balama natural graphite inventory depleted to 2kt
- Production at Vidalia related only to AAM qualification processes
- Continued progress in Vidalia AAM qualification processes with customers
- Vidalia AAM sales expected this year, with timing dependent on qualification progress and market conditions
- Quarter end cash balance of US$87m, including US$58m restricted cash
- Syrah awarded US$165 million Section 48C tax credit for the Vidalia Further Expansion project
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$35 |
Change in substantial holding for CYB
|
30 Jan 2025 9:21AM |
$0.160 |
$0.130 |
fallen by
18.75%
|
|
| AUCyber Limited (CYB) ORDINARY FULLY PAID |
Information Technology |
$17 |
Change in substantial holding from 5GN
|
30 Jan 2025 9:21AM |
$0.135 |
$0.080 |
fallen by
40.74%
|
|
| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
$53 |
Quarterly Activities Report and Appendix 4C
|
30 Jan 2025 9:21AM |
$0.031 |
$0.034 |
risen by
9.68%
|
|
TYP - Price-sensitive ASX Announcement
Full Release
Key Points
- TRP-8803 completion of Phase 1b study showing safety and tolerability.
- Interim analysis of Phase 2a IBS study showed 75% patient pain reduction.
- Raised $6 million from new and existing investors.
- Cash at bank was $2.8 million as of December 31, 2024.
- Company positioned to advance clinical trials in 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Godolphin Resources Limited (GRL) ORDINARY FULLY PAID |
Materials |
$29 |
Up to 42.7m Sulphide Mineralisation Intersected Lewis Ponds
|
30 Jan 2025 9:20AM |
$0.014 |
$0.041 |
risen by
192.86%
|
|
GRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Four drill holes totaling 1,094.8m have been drilled at the Lewis Ponds Project.
- Final two drill holes intersected further encouraging base metal mineralisation.
- GLPDD008 intersected 20.25m of massive, semi-massive and disseminated sulphide mineralisation.
- GLPDD009 intersected 42.7m of massive, semi-massive and disseminated sulphide mineralisation.
- Existing JORC 2012 Inferred Resource of 6.20 Mt at 2.0g/t gold, 80g/t silver, 2.7% zinc, 1.6% lead and 0.2% copper.
- Assay results from drill holes GLPDD006 and GLPDD007 are expected soon.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| A1 Investments & Resources Ltd (AYI) ORDINARY FULLY PAID |
Financials |
- |
Appendix 4C
|
30 Jan 2025 9:20AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Alterity Therapeutics Limited (ATH) ORDINARY FULLY PAID |
Health Care |
$92 |
Positive ATH434 Phase 2 Results Led By Clinical Efficacy
|
30 Jan 2025 9:20AM |
$0.008 |
$0.009 |
risen by
6.25%
|
|
ATH - Price-sensitive ASX Announcement
Full Release
Key Points
- ATH434 Phase 2 trial showed significant slowing of clinical progression in MSA.
- The 50 mg dose achieved a 48% reduction in clinical decline.
- Robust MRI biomarker results indicated iron stabilization in key brain areas.
- ATH434 was well-tolerated with no serious adverse events related to the drug.
- The study involved 77 participants across 23 global sites.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OpenLearning Limited (OLL) ORDINARY FULLY PAID |
Information Technology |
$28 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2025 9:19AM |
$0.019 |
$0.036 |
risen by
89.47%
|
|
OLL - Price-sensitive ASX Announcement
Full Release
Key Points
- Platform SaaS annual recurring revenue grew 23% YoY to $2.335 million in Q4 FY24.
- Average revenue per B2B SaaS customer increased 17% YoY to $9,767 per annum.
- Cash receipts from customers rose 45% YoY to $1.084 million.
- Net operating cash outflows decreased by 52% YoY to $0.365 million.
- CourseMagic.ai gained 126 active B2C customers and contributed to SaaS revenue growth.
- The company signed its first higher education customers through a partnership with Meshed Group.
- OpenLearning is expanding into international student recruitment via The Uni Guide.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tesoro Gold Ltd (TSO) ORDINARY FULLY PAID |
Materials |
$215 |
Quarterly Cashflow Report
|
30 Jan 2025 9:19AM |
$0.022 |
$1.210 |
risen by
5,400%
|
|
TSO - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash from operating activities was negative at $100,000.
- Exploration and evaluation costs amounted to $2.8 million.
- Ending cash and cash equivalents were reported at $3.86 million.
- The estimated available quarters of funding is approximately 1.31.
- The company expects to continue operations and achieve business objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GTI Energy Ltd (GTR) ORDINARY FULLY PAID |
Materials |
- |
Two Water Wells Completed & Staking Finalised at Lo Herma
|
30 Jan 2025 9:19AM |
$0.003 |
$0.130 |
risen by
4,233.33%
|
|
GTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Two groundwater monitoring wells drilled and completed
- Drilling of third groundwater monitoring well in progress
- Staking of additional claims finalised
- Performance Rights vested following successful resource upgrade
- Groundwater monitoring holes will facilitate testing of hydraulic parameters
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nexion Group Ltd (NNG) ORDINARY FULLY PAID |
Information Technology |
$4 |
NNG Quarterly Activities Report and Appendix 4C Dec-24
|
30 Jan 2025 9:19AM |
$0.020 |
$0.020 |
fallen by
0%
|
|
| Tivan Limited (TVN) ORDINARY FULLY PAID |
Materials |
$766 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2025 9:19AM |
$0.113 |
$0.340 |
risen by
202.22%
|
|
TVN - Price-sensitive ASX Announcement
Full Release
Key Points
- Commencement of ground-disturbing works at the Speewah Fluorite Project.
- Speewah Fluorite Project awarded Major Project Status.
- Received a $7.4 million cash grant under the IPCM Program.
- MoU signed with Sumitomo Corporation for a joint venture.
- Regulatory approval secured for drilling at the Sandover AI Project.
- Mineral Exploration Deeds secured with Central Land Council for Sandover Project.
- High-grade fluorite assays returned from Sandover Fluorite Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Marmota Limited (MEU) ORDINARY FULLY PAID |
Energy |
$165 |
Trading Halt
|
30 Jan 2025 9:18AM |
$0.063 |
$0.140 |
risen by
122.22%
|
|
MEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Marmota Limited requested a trading halt for its securities.
- The halt is pending an announcement regarding capital raising.
- The trading halt will last until February 3, 2025, or until the announcement is made.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$30 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2025 9:18AM |
$0.018 |
$0.037 |
risen by
105.56%
|
|
AT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Atomo secures an order worth $440k for supply of HIV Self-Tests in Australia.
- Atomo executes a $2.44M CRC-P Grant with the Australian Federal Government.
- Total revenue of $1.2m for Q2 FY25, bringing total H1 revenue to ~$2.1m.
- Cash receipts from customers during the quarter were $1.7m.
- Atomo continues to see growth in its HIV Self-Test business.
- The company has onboarded 41 new pharmacies in Australia.
- Atomo is developing a novel rapid test for syphilis.
- Atomo finished the quarter debt-free with cash on hand of $2.9m.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
